⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Intratumoral Cancer Therapies Market to Reach USD 630.7 Million by 2033 as Next-Generation Localized Immunotherapies Transform Solid Tumor Treatment
prnewswire.com
PFE
BMY
BBIO
BSX
DNA Damaging Agents Market Grows at 11.67% CAGR, to Hit USD 46.31 Billion by 2034
globenewswire.com
XRAY
NVS
RUC
NIRA
TLZ
AZN
BMY
MRK
Sean Callagy Launches Unblinded 2025 Initiative to Redefine Influence and Leadership Worldwide
accessnewswire.com
TMUS
DIS
BMY
CRM
MA
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
businesswire.com
BMY
Geronimo Power Hosts Community Event in Texas at Blevins Solar & Storage
prnewswire.com
FUJIY
BMY
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
globenewswire.com
CYTK
BAYRY
LLY
BCDA
MESO
TNSA
NVO
AZN
BMY
ITCI
JNJ
AMGN
ARWR
Liver Cancer Drug Market Poised to Reach US$ 17.2 Billion by 2033 Amid Rapid Advances in Targeted Therapies | Astute Analytica
globenewswire.com
BMY
MRK
AZN
ELVN
REGN
GILD
NVS
SNY
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight
globenewswire.com
GSK
TREVI
MRK
AZN
SNY
TEVA
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL
Companies Prioritize Revenue Performance with AI, ISG Says
businesswire.com
III
ANAB
XACT
ORCL
CRM
SAP
WDAY
ACN
IBM
MSFT
GOOG
AMZN
ADBE
NOW
INTU
PAYX
FIS
PAYC
SNOW
DDOG
MDB
PLTR
AI
SMCI
NVDA
AMD
INTC
QCOM
META
NFLX
CMCSA
VZ
T
CSCO
HPQ
DELL
PANW
CRWD
FTNT
ZBRA
CDNS
SNPS
MRVL
NXPI
MU
WDC
AMAT
LRCX
KLAC
ASML
ADI
TXN
ON
MPWR
AEHR
ARM
AVGO
AMGN
GILD
BMY
PFE
MRK
JNJ
LLY
ABBV
MDT
ISRG
BIIB
REGN
AZN
NVS
RHHBY
XOM
CVX
SHEL
TCEHY
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
YY
BEKE
NIO
LI
XPEV
RIVN
LCID
TSLA
GM
F
STLA
TM
HMC
VWAGY
BMW
DAI
GE
HON
BA
LMT
RTX
GD
NOC
CAT
DE
AGCO
CNH
J
CHTR
CMCSK
TMUS
ATVI
EA
TTWO
DIS
FOX
PARA
WBD
LYV
AMC
NCLH
CCL
RCL
DAL
UAL
AAL
LUV
JBLU
ALK
MAR
HLT
IHG
WYNN
LVS
MGM
CHKP
Zscaler
AKR
VAR
NICE
BOARD
FORM
PIG
INFSPM
PERF
FULL
CAP
EVER
JED
OPT
XOXO
ELEV
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma
businesswire.com
BMY